Investigators seeking to evaluate short-chain peptide regulatory mechanisms in inflammatory signaling pathways can acquire analytical-grade Chonluten directly from PX1 Research. Designed strictly for in vitro assays and preclinical models, our synthetic Chonluten features verifiable high purity confirmed via lot-specific mass spectrometry and liquid chromatography. Explore how this synthetic tripeptide is utilized in laboratory research investigating tumor necrosis factor-alpha (TNF-α) regulation and respiratory tissue dynamics.
Investigators seeking to evaluate short-chain peptide regulatory mechanisms in inflammatory signaling pathways can acquire analytical-grade Chonluten directly from PX1 Research. Designed strictly for in vitro assays and preclinical models, our synthetic Chonluten features verifiable high purity confirmed via lot-specific mass spectrometry and liquid chromatography. Explore how this synthetic tripeptide is utilized in laboratory research investigating tumor necrosis factor-alpha (TNF-α) regulation and respiratory tissue dynamics.
To buy peptide TNF inhibition Chonluten for controlled laboratory experiments, research facilities require high-purity, fully characterized synthetic material. Chonluten is a synthetic tripeptide (L-Glu-L-Asp-L-Gly) investigated in preclinical models for its potential to modulate inflammatory cascades, particularly by downregulating pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α). PX1 Research provides USA-manufactured Chonluten certified via RP-HPLC and mass spectrometry to ensure sequence fidelity and lot-to-lot consistency in cellular and tissue assays.
When designing protocols around cytokine expression, researchers rely on precise molecular tools that are free of endotoxins and organic contaminants. PX1 Research supports institutional research by providing fully documented, highly pure compounds backed by transparent quality control protocols. Researchers can explore our full selection of specialized tools in the comprehensive PX1 product catalog.
Chonluten is a synthetic short-chain peptide comprising three amino acid residues: L-glutamic acid, L-aspartic acid, and glycine (sequence: Glu-Asp-Gly). Belonging to the class of short peptide bioregulators initially identified in organ-specific protein hydrolysates, Chonluten is engineered to mimic natural peptide-chromatin interaction dynamics. Its low molecular weight allows for efficient cellular uptake in culture systems, making it an ideal candidate for probing intracellular transcription mechanisms.
In biochemical investigations, short peptides like Chonluten are hypothesized to penetrate cellular and nuclear membranes without requiring specialized transporter systems. Once inside the nucleus, preclinical evidence suggests these short sequences interact directly with specific histone proteins and DNA promoter regions, modulating gene expression profiles responsible for inflammatory signaling and cellular repair. For a deeper analysis of short peptide dynamics, visit our dedicated peptide research library.
Tumor necrosis factor-alpha (TNF-α) serves as a primary driver of acute and chronic inflammatory cascades in mammalian biology. Elevated levels of TNF-α stimulate downstream signaling pathways, including Nuclear Factor kappa B (NF-κB) and mitogen-activated protein kinases (MAPK), which trigger hyper-inflammatory responses and cellular damage. Preclinical research models evaluating cytokine pathway research indicate that short peptides such as Chonluten may exert homeostatic control by suppressing the transcription of pro-inflammatory cytokines under oxidative or stress-induced conditions.
In vitro data suggest that exposure to Chonluten prior to or during inflammatory challenge leads to a measurable reduction in TNF-α RNA expression and protein secretion in bronchial epithelial cells and macrophages. By dampening TNF-α upregulation, the peptide helps maintain structural integrity in cellular monolayer assays and reduces cellular apoptosis associated with prolonged hyper-inflammation. Understanding these underlying genomic interactions remains a key focus of current pulmonary and immunological research.
Preclinical studies utilizing animal models of pulmonary damage—such as lipopolysaccharide (LPS)-induced acute lung injury in rodents—have investigated the biological activity of Chonluten. Investigators observing tissue architecture noted that treatment with short regulatory peptides reduced neutrophil infiltration, alveolar edema, and structural degradation in pulmonary tissue. These observed protective effects correlated closely with a marked reduction in localized TNF-α, IL-1β, and IL-6 expression.
Furthermore, organotypic cell culture experiments involving human bronchial epithelial cells demonstrate that Chonluten application supports cellular repair mechanisms following chemical or oxidative challenge. Researchers evaluating the compound note an increase in surfactant protein expression and cell viability markers alongside TNF suppression. To examine specific analytical-grade formats, scientists can view the Chonluten 10mg product specifications.
When designing comparative assays targeting inflammatory signaling or tissue-specific gene expression, investigators frequently evaluate Chonluten alongside other short-chain bioregulators. While Chonluten (Glu-Asp-Gly) is predominantly studied for its activity in respiratory epithelial models and TNF-α suppression, related compounds display distinct organ-specific targeted profiles.
For instance, Bronchogen (Ala-Glu-Asp-Leu) is similarly investigated in bronchial model systems but possesses a four-amino-acid structure tailored toward lung repair pathways. In contrast, Vilon (Lys-Glu) focuses heavily on systemic immune regulation and fibroblast proliferation, whereas Thymogen (Glu-Trp) is predominantly utilized in T-cell maturation and general immunomodulatory assays. Comparing these distinct sequences within the broader family of Khavinson bioregulators provides researchers with a versatile toolkit for dissecting localized versus systemic inflammatory responses.
Reliable scientific research depends on consistent compound quality and verified chemical identity. When purchasing peptides for precision bioassays, variance in peptide purity or the presence of residual TFA (trifluoroacetic acid) can compromise cell viability and alter cytokine expression data. PX1 Research implements rigid quality assurance measures to guarantee batch consistency across all research compounds.
Every lot of synthetic Chonluten manufactured for PX1 Research undergoes rigorous testing in ISO 17025 accredited analytical laboratories. Quality verification includes:
• Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm purity profiles exceeding 98%.
• Electrospray Ionization Mass Spectrometry (ESI-MS) to verify exact molecular weight and amino acid sequence identity.
• Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below strictly controlled thresholds (<0.01 EU/mg).
• Comprehensive Certificates of Analysis (COAs) provided with every shipment for full lot traceability.
Chonluten is supplied as a sterile, lyophilized (freeze-dried) powder to maximize chemical stability during transport and storage. For in vitro and cell culture applications, proper reconstitution techniques are critical to prevent peptide degradation and ensure uniform concentration throughout experimental trials.
Researchers preparing working solutions should observe standard aseptic laboratory protocols:
1. Reconstitution Medium: Dissolve the lyophilized powder in sterile, bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) depending on assay requirements.
2. Dissolution Technique: Gently swirl or invert the vial to allow complete dissolution. Avoid aggressive vortexing or sonicating, which may introduce shear stress or foam.
3. Stock Concentrates: Prepare high-concentration stock solutions (e.g., 1–5 mg/mL) using sterile technique within a laminar flow hood.
4. Aliquoting: Divide reconstituted solutions into single-use micro-centrifuge tubes to minimize freeze-thaw cycles prior to working dilution in culture media.
Proper storage conditions are required to maintain peptide structural integrity and prevent hydrolytic cleavage over extended periods. Lyophilized Chonluten should be stored in a commercial freezer at -20°C or -80°C upon receipt, protected from moisture and light exposure.
Under sub-zero conditions (-20°C), dry powder forms remain stable for up to 24 months without measurable loss of purity. Once reconstituted into liquid buffers, stock solutions should be kept at 4°C for short-term use (up to 7 days) or aliquoted and stored at -80°C for long-term storage (up to 6 months). Avoid repeated freeze-thaw cycles, as micro-ice crystal formation can degrade short peptide chains and yield inconsistent experimental results.
PX1 Research is a dedicated provider of research-grade peptides for academic, biotechnology, and institutional laboratories across the United States. We eliminate supply-chain ambiguity by manufacturing compounds exclusively in domestic, GMP-compliant facilities subject to stringent quality standards.
All orders ship rapidly from our centralized distribution hubs in California and Arizona, utilizing ambient or cold-chain packaging as required by product stability profiles. Orders placed Monday through Friday ship same-day, ensuring fast delivery for time-sensitive research timelines. Institutional buyers seeking volume pricing or routine laboratory supply can establish dedicated support through our bulk research accounts program.
What is the primary sequence and molecular weight of Chonluten?
Chonluten is a synthetic tripeptide consisting of L-glutamic acid, L-aspartic acid, and glycine (sequence: H-Glu-Asp-Gly-OH). It has a theoretical molecular weight of approximately 305.24 g/mol.
What preclinical evidence connects Chonluten to TNF-α inhibition?
In vitro cellular assays and rodent models of pulmonary inflammation demonstrate that Chonluten exposure leads to a statistically significant downregulation of pro-inflammatory cytokines, specifically tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), at the transcriptional level.
How does PX1 Research verify the purity of Chonluten?
Every lot of Chonluten undergoes analytical testing via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity verification and Mass Spectrometry (MS) for sequence identity confirmation. Endotoxin testing via LAL assay is also performed.
Can Chonluten be reconstituted directly in cell culture media?
While Chonluten is water-soluble, standard laboratory protocols recommend reconstituting the lyophilized powder in sterile WFI or PBS to form a stock solution, which is then diluted into working culture media to achieve target concentrations.
What is the recommended storage temperature for lyophilized Chonluten?
Lyophilized Chonluten powder should be stored long-term at -20°C or -80°C in a desiccated container protected from light. Reconstituted aliquots should be stored at -80°C to preserve stability.
What are the typical endotoxin limits for PX1 Research compounds?
PX1 Research compounds undergo strict endotoxin screening via quantitative LAL testing to ensure levels remain below <0.01 EU/mg, minimizing interference in sensitive cell culture assays.
How does Chonluten differ structurally from Bronchogen?
Chonluten is a tripeptide (Glu-Asp-Gly), whereas Bronchogen is a tetrapeptide (Ala-Glu-Asp-Leu). Both are studied for respiratory tissue bioregulation, but they possess distinct primary sequences and target binding kinetics.
Is Chonluten approved for human therapeutic use or clinical treatment?
No. Chonluten provided by PX1 Research is strictly sold as a research chemical for in vitro assays, cellular models, and preclinical laboratory investigation. It is not intended for human consumption, medical diagnosis, or therapeutic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.